Galmed Pharmaceuticals to Present Late-Breaking Data at HEP-DART 2025 Meeting Galmed Pharmaceuticals announces a late-breaking abstract presentation at HEP-DART 2025, revealing new insights on their drug Aramchol's efficacy combined with regorafenib.

Galmed Pharmaceuticals to Present Late-Breaking Data at HEP-DART 2025 Meeting #Israel #Galmed_Pharmaceuticals #Aramchol #Regorafenib #Ramot_Gan